| Customization: | Available |
|---|---|
| Application: | Injection |
| Usage Mode: | Injection |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Ceftriaxone is commonly used in the treatment of community-acquired pneumonia, mild to moderate healthcare-associated pneumonia, bacterial meningitis, and febrile infants between 4 and 8 weeks of age.
Ceftriaxone is contraindicated in neonates requiring treatment with calcium-containing IV solutions.
Specific side effects include hypoprothrombinaemia, bleeding, haemolysis, and rare biliary sludging.
Ceftriaxone can interact with medications such as Warfarin, Sulfinpyrazone, and Calcium.
Prior hypersensitivity reactions to cephalosporins or penicillins should be considered before therapy. Caution is advised in penicillin-sensitive patients.
Ceftriaxone is excreted in small amounts in human milk and is considered compatible with breastfeeding.
No specific antidote is available for ceftriaxone overdose. Symptomatic treatment is recommended.
Store below 25ºC, protect from moisture, and keep out of reach of children.
| Testing terms | Standards | Results |
| Shape | It is white or off-white crystalline powder; odorless | white crystalline powder; odorless |
| pH | 6.0~8.0 | 6.6 |
| Water | 8.0%~11.0% | 8.4% |
| Relative substance | Single heterogeneity ≤ 1.0% Total miscellaneous response ≤4.0% |
0.1% 0.3% |
| Loading difference | Comply with the standard | Conformity |
| Visible foreign matter | Comply with the standard | Conformity |
| Assay | 90.0%-110.0% | 99.7% |
){kind=link}